Medistim ASA Statistics

Total Valuation

Medistim ASA has a market cap or net worth of GBP 208.72 million. The enterprise value is 200.18 million.

Market Cap	208.72M
Enterprise Value	200.18M

Important Dates

The next estimated earnings date is Friday, February 28, 2025.

Earnings Date	Feb 28, 2025
Ex-Dividend Date	Apr 25, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.17%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	12.30M

Valuation Ratios

The trailing PE ratio is 28.98.

PE Ratio	28.98
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	8.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.73, with an EV/FCF ratio of 28.16.

EV / Earnings	27.80
EV / Sales	5.19
EV / EBITDA	18.73
EV / EBIT	22.04
EV / FCF	28.16

Financial Position

The company has a current ratio of 4.82, with a Debt / Equity ratio of 0.02.

Current Ratio	4.82
Quick Ratio	2.75
Debt / Equity	0.02
Debt / EBITDA	0.05
Debt / FCF	0.07
Interest Coverage	844.30

Financial Efficiency

Return on equity (ROE) is 25.95% and return on invested capital (ROIC) is 20.05%.

Return on Equity (ROE)	25.95%
Return on Assets (ROA)	16.50%
Return on Invested Capital (ROIC)	20.05%
Return on Capital Employed (ROCE)	30.83%
Revenue Per Employee	254,241
Profits Per Employee	47,692
Employee Count	151
Asset Turnover	1.12
Inventory Turnover	0.75

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.95% in the last 52 weeks. The beta is 0.76, so Medistim ASA's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	-29.95%
50-Day Moving Average	168.79
200-Day Moving Average	208.39
Relative Strength Index (RSI)	42.41
Average Volume (20 Days)	191

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medistim ASA had revenue of GBP 38.39 million and earned 7.20 million in profits. Earnings per share was 0.39.

Revenue	38.39M
Gross Profit	30.30M
Operating Income	9.03M
Pretax Income	9.38M
Net Income	7.20M
EBITDA	10.04M
EBIT	9.03M
Earnings Per Share (EPS)	0.39

Full Income Statement

Balance Sheet

The company has 9.02 million in cash and 529,493 in debt, giving a net cash position of 8.49 million.

Cash & Cash Equivalents	9.02M
Total Debt	529,493
Net Cash	8.49M
Net Cash Per Share	n/a
Equity (Book Value)	28.70M
Book Value Per Share	1.57
Working Capital	20.96M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.27 million and capital expenditures -1.16 million, giving a free cash flow of 7.11 million.

Operating Cash Flow	8.27M
Capital Expenditures	-1.16M
Free Cash Flow	7.11M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 78.92%, with operating and profit margins of 23.53% and 18.76%.

Gross Margin	78.92%
Operating Margin	23.53%
Pretax Margin	24.42%
Profit Margin	18.76%
EBITDA Margin	26.15%
EBIT Margin	23.53%
FCF Margin	18.52%

Dividends & Yields

Medistim ASA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	-3.70%
Years of Dividend Growth	n/a
Payout Ratio	80.85%
Buyback Yield	-0.17%
Shareholder Yield	-0.17%
Earnings Yield	3.45%
FCF Yield	3.41%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a